Brief: Chromadex Corporation Reports Q3 2022 Financial Results

Niagen Bioscience

02/11/2022 20:21

Nov 2 (Reuters) - Chromadex Corp  CDXC.O :
    * ORATION REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
    * Q3 LOSS PER SHARE $0.01
    * QTRLY TOTAL NET SALES WERE $17.1 MILLION,  DOWN 1%
    * Q3 EARNINGS PER SHARE VIEW $-0.06, REVENUE VIEW $18.7
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nBw3xKf4ca 
Further company coverage:  CDXC.O 
 ((Reuters.Briefs@thomsonreuters.com;))